Reaction
Genotype Drug Resistance Test Positive reporting signals
As of the last recalculation, Genotype Drug Resistance Test Positive appears in 1,025 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is SOFOSBUVIR (PRR 293.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sofosbuvir | 223 | 293.1 | 296.4 |
| Tenofovir Disoproxil Fumarate Tablets | 78 | 198.5 | 200.3 |
| Ledipasvir And Sofosbuvir | 112 | 132.7 | 133.5 |
| Velpatasvir And Sofosbuvir | 71 | 120.6 | 121.3 |
| Darunavir | 68 | 97.7 | 98.2 |
| Tenofovir Disoproxil Fumarate | 137 | 97.0 | 97.4 |
| Efavirenz | 46 | 87.7 | 88.0 |
| Entecavir | 47 | 85.6 | 86.0 |
| Lamivudine Oral | 95 | 83.9 | 84.3 |
| Lamivudine | 104 | 76.0 | 76.2 |
| Nevirapine | 31 | 71.9 | 72.2 |
| Raltegravir | 55 | 71.4 | 71.7 |
| Ribavirin | 180 | 68.7 | 68.9 |
| Zidovudine | 41 | 64.8 | 65.0 |
| Dolutegravir Sodium | 27 | 62.4 | 62.6 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 51 | 60.1 | 60.3 |
| Ritonavir | 73 | 54.5 | 54.7 |
| Ritonavir 100 Mg | 37 | 52.1 | 52.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 23 | 47.5 | 47.6 |
| Atazanavir | 30 | 43.6 | 43.7 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 83 | 40.1 | 40.2 |
| Lopinavir And Ritonavir | 24 | 36.8 | 36.9 |
| Abacavir Sulfate | 16 | 33.9 | 33.9 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 14 | 32.0 | 32.0 |
| Emtricitabine And Tenofovir Alafenamide | 12 | 21.7 | 21.8 |